Both PD-1 ligands have previously been implicated in different types of cancer, although more is known about PD-L1 expression in several types of tumors, such as melanoma, brain tumors, lung cancer, urothelial cancer and pancreatic cancer [7, 35–38]. Here, CD274 is linked to lung carcinoma.